Elder Pharmaceuticals is trading higher by 4% to Rs 368 after the company said its board approved restructuring of the company business to reduce debt. “The board with a view to reducing the debt of the company approved the proposal for carrying out restructuring of Company's business involving either raising of capital, hiving off of assets or other strategic options and have decided to appoint advisors for this purpose,” Elder Pharma said in a BSE filing.